DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Betibeglogene autotemcel
Betibeglogene autotemcel
Abstract Book
Horizon Scanning Status Report, Volume 2
PDCO Minutes 20-23 April 2021
Horizon Scanning Status Report December 2020
Long-Term Data for Bluebird Bio's Gene Therapy for Β-Thalassaemia
New Data from Phase 3 Studies Support Maintained Transfusion
62° AMERICAN SOCIETY of HEMATOLOGY Virtual Congress, 5-8 Dicembre 2020 W W W
Bluebird Bio Announces Temporary Suspension on Phase 1/2 and Phase 3 Studies of Lentiglobin Gene Therapy for Sickle Cell Disease (Bb1111)
Zynteglo 1.2-20 × 106 Cells/Ml Dispersion for Infusion
(AML) in Lentiglobin for Sickle Cell Disease
Zynteglo: EPAR
Meds Entry Watch New Medicines Approved in 2019
TAG Mail – 17 Dec 2020
Minutes of the CHMP Meeting 17-20 May 2021
ATC Vet 2021 Atccode Atcdescription Atcdescriptionsi QA ALIMENTARY TRACT and METABOLISM ZDRAVILA ZA BOLEZNI PREBAVIL in PRESNOVE
Novel Therapeutic Advances in Β-Thalassemia
International Nonproprietary Names for Pharmaceutical Substances (INN)
Wissenschaftliches Programm Freitag, 09. Oktober 2020 Akute
Top View
Betibeglogene Autotemcel (Zynteglo°) in Certain Forms of Severe Beta
Klasifikacija ATC 2021
PRAC Draft Agenda of Meeting 7-10 June 2021
Β-Thalassemias Ali T
Innovative Treatments for Rare Anemias
Publication Agenda CHMP 07-10 December 2020
Horizon Scanning Status Report, March 2021, Volume 3, Issue 1
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and Β-Thalassemia
The 47Th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001 – P182)